NCLT Approves Bajaj Healthcare's Acquisition of Genrx Pharma

Bajaj Healthcare Limited has received approval from the Hon'ble National Company Law Tribunal (NCLT), Mumbai Bench, for the acquisition of Genrx Pharmaceuticals Private Limited on a going concern basis. This order, dated October 13, 2026, follows earlier disclosures made by the company. Genrx Pharmaceuticals Private Limited will become a Wholly Owned Subsidiary of Bajaj Healthcare Limited upon implementation of the NCLT order. The trading window for dealing in Bajaj Healthcare Limited's securities remains closed for designated persons.